Compositions and methods for inhibiting the synthesis or expression of MMP-1

The present invention relates to the specific inhibition of matrix metalloproteinase 1 (MMP-1) using agents which inhibit the synthesis or expression of MMP-1. Such agents are useful for suppressing invasion or metastasis of a tumor cell and in the treatment, prevention and management of cancer.

Patents:
US 20,090,270,487

Inventor(s): WYATT COLBY A [US]; BRINCKERHOFF CONSTANCE F [US]

Type of Offer: Licensing



« More Biotech Patents

---